Sulforaphane‑induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco‑2 cells

  • Authors:
    • Jia‑Wei Zhou
    • Min Wang
    • Nuan‑Xin Sun
    • Ying Qing
    • Teng‑Fei Yin
    • Cui Li
    • Dong Wu
  • View Affiliations

  • Published online on: July 5, 2019     https://doi.org/10.3892/ol.2019.10569
  • Pages: 2639-2647
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the mechanism underlying sulforaphane‑mediated epigenetic regulation of nuclear factor‑erythroid derived 2‑like 2 (Nrf2) expression in human colon cancer. Proteins were extracted from normal Caco‑2 cells using sulforaphane and 5‑aza‑2'‑deoxycytidine (5‑Aza) combined with trichostatin A (TSA). The mRNA and protein expression levels and activity of DNA methyltransferase 1 (DNMT1) were determined. Methylation‑specific polymerase chain reaction and bisulfite genomic sequencing were also used to measure the methylation levels of CpG sites in the Nrf2 promoter region. Nrf2 expression was measured using reverse transcription‑quantitative PCR and western blot analysis. The results demonstrated that sulforaphane did not affect DNMT1 mRNA expression levels. DNMT1 protein expression was inhibited by sulforaphane and 5‑Aza co‑treatment with TSA. Nrf2 promoter methylation decreased significantly in the sulforaphane group compared with the control group. Nrf2 promoter methylation level in the 5‑Aza+TSA group was the lowest among all groups. Nrf2 mRNA levels exhibited significant differences between the sulforaphane‑treated and control groups, as well as between the 5‑Aza+TSA and control groups, and the sulforaphane‑treated and 5‑Aza+TSA groups. Nrf2 protein expression was also inhibited by sulforaphane, as well as 5‑Aza co‑treatment with TSA. The results revealed that sulforaphane may promote demethylation of the Nrf2 promoter region to increase activation of Nrf2, which induces chemoprevention of colon cancer.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhou JW, Wang M, Sun NX, Qing Y, Yin TF, Li C and Wu D: Sulforaphane‑induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco‑2 cells. Oncol Lett 18: 2639-2647, 2019.
APA
Zhou, J., Wang, M., Sun, N., Qing, Y., Yin, T., Li, C., & Wu, D. (2019). Sulforaphane‑induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco‑2 cells. Oncology Letters, 18, 2639-2647. https://doi.org/10.3892/ol.2019.10569
MLA
Zhou, J., Wang, M., Sun, N., Qing, Y., Yin, T., Li, C., Wu, D."Sulforaphane‑induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco‑2 cells". Oncology Letters 18.3 (2019): 2639-2647.
Chicago
Zhou, J., Wang, M., Sun, N., Qing, Y., Yin, T., Li, C., Wu, D."Sulforaphane‑induced epigenetic regulation of Nrf2 expression by DNA methyltransferase in human Caco‑2 cells". Oncology Letters 18, no. 3 (2019): 2639-2647. https://doi.org/10.3892/ol.2019.10569